DNMT3A and acute myeloid leukemia: As previously reported, Dnmt3a+/-Flt3ITD mice develop AML [3] as evidenced by increased immature forms in the bone marrow and myeloblastic infiltration in liver and spleen as compared to wild-type control mice (Fig. 1B).